Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of SeretideTM (50/250 μg bd DiskusTM vs. formoterol (12 μg bd) and budesonide (800 μg bd) given concurrently (both via TurbuhalerTM) in patients with moderate-to-severe asthma
Author:
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference40 articles.
1. Global Initiative for Asthma, National Institutes of Health, National Heart, Lung and Blood Institute, Global strategy for asthma management and prevention
2. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids;Woolcock;Am J Respir Crit Care Med,1996
3. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma;van Noord;Thorax,1999
4. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group;Condemi;Ann Allergy Asthma Immunol,1999
5. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial;Kelsen;J Asthma,1999
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance;International Journal of Pharmaceutics;2023-08
2. Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy;The Journal of Allergy and Clinical Immunology: In Practice;2023-07
3. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events;Cochrane Database of Systematic Reviews;2021-04-14
4. Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer;Gastroenterology;2018-03
5. Assessing biomarkers in a real-world severe asthma study (ARIETTA);Respiratory Medicine;2016-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3